In January 2024, CNDH successfully made it to the list of "2023 Guangzhou Stars of Tomorrow" enterprises.

This honor was granted at the "2023 Guangzhou Top 20 and Stars of Tomorrow" award ceremony, which was jointly organized by the Guangzhou Science and Technology Bureau and Deloitte China, with guidance from the GBA Science and Technology Innovation Service Center.

This award signifies the recognition for CNDH from relevant authorities in various aspects such as industry influence, technological innovation, business models, market competition, and future potential.

This achievement is expected to positively impact the brand value and long-term development of CNDH.

As a strategic service provider focusing on revolutionary rapid testing technology for rapid diagnostic market, CNDH has been dedicated to the research and production of rapid testing products and achieving scalable sales globally.

Our business primarily revolves around public safety testing and animal disease testing, combining diagnostic reagents, analytical instruments, and data platforms to form an integrated solution.

With a portfolio of 74 patents, our products are distributed across the country and overseas, and we collaborate with institutions such as the National Anti-Drug Laboratory Guangdong Branch and the Food and Drug Investigation Department of the Guangdong Provincial Public Security Department to establish joint laboratories, using our technology to support public safety.

CNDH remain committed to using technological innovation to enhance global public safety, safeguarding human life and health as our mission, and striving to elevate the level of technological industrialization.